BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, December 16, 2025
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Financings for April 2, 2020

April 2, 2020
Med-tech firms raising money in public or private financings, including: Cooper Companies, Invitae, Medgenome, Nevro.
Read More

Appointments and advancements for April 2, 2020

April 2, 2020
New hires and promotions in the med-tech industry, including: Castle Biosciences, Curvafix, E-therapeutics, Invo Bioscience, Nexgel, Sera Prognostics.
Read More

Regulatory actions for March 31, 2020

April 2, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cytosorbents, Enlightenvue, Qiagen, Siemens Healthineers.
Read More

Regulatory actions for April 2, 2020

April 2, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Affimed, Applied, Celularity, Fera, Nicox, Pfizer, Pharmamar, Seattle Genetics.
Read More

Other news to note for April 2, 2020

April 2, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: AC Immune, Adaptive, Advanz, Aicuris, Alnylam, Amgen, Ansun, Apeptico, Astrazeneca, Aurobindo, Axxam, Bharat, Bioaegis, Celator, Celularity, Cobra, Combigene, Cortexyme, Cytodyn, Elevation, Ennaid, ERS, Evotec, Flugen, Foamix, 14ner, Ipsen, Kite, La Jolla, Leo, Menlo, Merck, Merrimack, Novartis, Noxopharm, Paratek, Perrigo, Persephone, Ra, Redhill, Relief, Sandoz, Serimmune, Sonnet, Sorrento, Tetra, Teva, UCB, Vir, Zealand.
Read More

In the clinic for April 2, 2020

April 2, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Algernon, Apeiron, Arena, Atara, Athera, Axial, Biogen, Dermavant, Eiger, Fulcrum, Geron, I-Mab, Mateon, Merck, Moleculin, Momenta, Noxxon, Oncolytics, Rhovac, Valbiotis, VBL, Xbrane, Zymeworks.
Read More

Financings for April 2, 2020

April 2, 2020
Biopharmas raising money in public or private financings, including: Calviri, Dynacure, Rgenta.
Read More

Appointments and advancements for April 2, 2020

April 2, 2020
New hires and promotions in the biopharma industry, including: Actimed, Biocryst, Curevac, E-therapeutics, Galera, Insmed, Oric, Replimune, Stridebio.
Read More

Other news to note for March 30, 2020

April 2, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3D Medicines, Alphamab, Altimmune, Amgen, Aptorum, Aravive, Astrazeneca, Bellerophon, Benitec, Cobra, Compass, Covar, Curetis, Diverse, Forty Seven, Genexine, Gigagen, Gilead, Harmony, Hoth, I-Mab, Imaginab, IMV, Isoprene, Lifemax, Moderna, Nanotx, Noveome, Numab, Olix, Ono, Opgen, Plus, Simcere, Surrozen.
Read More

Regulatory actions for April 1, 2020

April 1, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: ABM Respiratory Care, Crossbay Medical.
Read More
Previous 1 2 … 1573 1574 1575 1576 1577 1578 1579 1580 1581 … 1717 1718 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 16, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 16, 2025.
  • Businesspeople shaking hands, meeting with cityscape, charts

    Deals and an M&A strengthen end-of-year numbers

    BioWorld
    Two large deals and an acquisition, totaling about $4.64 billion in all, are helping wrap up what’s turning out to be a strong year. Through the first 11 months...
  • Illustration of tau accumulating in a neuron cell.

    ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug

    BioWorld
    ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
  • PET imaging

    Radiopharm Theranostics’ RAD-101 meets brain metastases endpoints

    BioWorld
    Radiopharm Theranostics Ltd.’s radiotracer RAD-101 met the primary endpoint in 92% of patients in the phase IIb imaging trial in brain metastases, according to...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing